AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic Dermatitis

Eric Volkman, The Motley Fool
·2 min read
AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic Dermatitis
AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic Dermatitis

Already given the green light for rheumatoid arthritis, the drug could soon be prescribed for a common skin ailment.